510 related articles for article (PubMed ID: 28212891)
1. Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation.
Shawky NM; Segar L
Pharmacol Res; 2017 May; 119():251-264. PubMed ID: 28212891
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
Osman I; Segar L
Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
[TBL] [Abstract][Full Text] [Related]
3. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
Fairaq A; Shawky NM; Osman I; Pichavaram P; Segar L
Pharmacol Res; 2017 May; 119():289-302. PubMed ID: 28237515
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane improves dysregulated metabolic profile and inhibits leptin-induced VSMC proliferation: Implications toward suppression of neointima formation after arterial injury in western diet-fed obese mice.
Shawky NM; Pichavaram P; Shehatou GS; Suddek GM; Gameil NM; Jun JY; Segar L
J Nutr Biochem; 2016 Jun; 32():73-84. PubMed ID: 27142739
[TBL] [Abstract][Full Text] [Related]
5. Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis.
Hwang YJ; Park JH; Cho DH
J Korean Med Sci; 2020 Sep; 35(35):e289. PubMed ID: 32893519
[TBL] [Abstract][Full Text] [Related]
6. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade.
Lu QB; Wan MY; Wang PY; Zhang CX; Xu DY; Liao X; Sun HJ
Redox Biol; 2018 Apr; 14():656-668. PubMed ID: 29175753
[TBL] [Abstract][Full Text] [Related]
7. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
[TBL] [Abstract][Full Text] [Related]
8. Far-Infrared Irradiation Decreases Proliferation in Basal and PDGF-Stimulated VSMCs Through AMPK-Mediated Inhibition of mTOR/p70S6K Signaling Axis.
Hwang YJ; Park JH; Cho DH
J Korean Med Sci; 2023 Oct; 38(41):e335. PubMed ID: 37873631
[TBL] [Abstract][Full Text] [Related]
9. PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates.
Zhao Y; Biswas SK; McNulty PH; Kozak M; Jun JY; Segar L
Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1375-85. PubMed ID: 21325637
[TBL] [Abstract][Full Text] [Related]
10. High fructose-mediated attenuation of insulin receptor signaling does not affect PDGF-induced proliferative signaling in vascular smooth muscle cells.
Osman I; Poulose N; Ganapathy V; Segar L
Eur J Pharmacol; 2016 Nov; 791():703-710. PubMed ID: 27729247
[TBL] [Abstract][Full Text] [Related]
11. The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner.
Zhang Y; Gilmour A; Ahn YH; de la Vega L; Dinkova-Kostova AT
Phytomedicine; 2021 Jun; 86():153062. PubMed ID: 31409554
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
13. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Ashino T; Yamamoto M; Yoshida T; Numazawa S
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1.
Ha JM; Yun SJ; Kim YW; Jin SY; Lee HS; Song SH; Shin HK; Bae SS
Biochem Biophys Res Commun; 2015 Aug; 464(1):57-62. PubMed ID: 26032503
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II Receptor Type 1 Antagonists Modulate Vascular Smooth Muscle Cell Proliferation and Migration via AMPK/mTOR.
Zhao Y; Shang F; Shi W; Zhang J; Zhang J; Liu X; Li B; Hu X; Wang L
Cardiology; 2019; 143(1):1-10. PubMed ID: 31307032
[TBL] [Abstract][Full Text] [Related]
16. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors.
Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484
[TBL] [Abstract][Full Text] [Related]
17. The inhibition of insulin-stimulated proliferation of vascular smooth muscle cells by rosiglitazone is mediated by the Akt-mTOR-P70S6K pathway.
Park S; Lim S; Chang W; Song H; Lee S; Song BW; Kim HJ; Cha MJ; Choi E; Jang Y; Chung N; Cho SY; Hwang KC
Yonsei Med J; 2008 Aug; 49(4):592-600. PubMed ID: 18729301
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 5-Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β-Arrestin2-Mammalian Target of Rapamycin/p70S6K Pathway.
Liu Y; Wang Z; Li J; Ban Y; Mao G; Zhang M; Wang M; Liu Y; Zhao B; Shen Q; Xu Q; Wang N
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29382665
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid decreases vascular smooth muscle cell proliferation via protein phosphatase 2A-mediated p70 S6 kinase inhibition.
Lee H; Hwang YJ; Park JH; Cho DH
Biochem Biophys Res Commun; 2022 May; 606():94-99. PubMed ID: 35339758
[TBL] [Abstract][Full Text] [Related]
20. Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift.
Han JH; Park HS; Lee DH; Jo JH; Heo KS; Myung CS
Life Sci; 2021 Feb; 267():118978. PubMed ID: 33412209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]